(5) Xinmailong Injection delays the development of cardiac hypertrophy by inhibiting the phosphorylation of extracellular regulated protein kinases 1/2, AKT, and GSK3β proteins and overexpression of the downstream factor GATA4 in the nucleus. Here, GSK3B is linked to cardiac hypertrophy.